Next-generation sequencing produces enormous amounts of data, and turning it into clinical answers requires robust bioinformatics. For molecular labs, NGS data analysis covers the whole chain: quality control, alignment, variant calling, CNV detection, annotation and interpretation, all within validated and compliant workflows.
In this section, we gather our articles on NGS data analysis for molecular labs: practical guides on building and scaling pipelines, insights on accuracy and turnaround time, regulatory topics such as IVDR, and stories from labs that use SeqOne to streamline their genomic workflows.

GermVar PGx, the first module of SeqOne Preventive Genomics, supports laboratories with pharmacogenomic analysis inside the germline workflow, from star-allele calling to the guideline recommendations their experts review and report.

Valencia’s General University Hospital brought HRD testing in-house with Agilent and SeqOne. A 30-case study showed matching classifications vs. commercial assays, fewer inconclusive results, and turnaround cut from ~20 to 6-7 days.

SomaHRD v2 reaches 97.1% concordance with Myriad MyChoice CDx and a PFS hazard ratio of 0.23, with a 4.8% non-conclusive rate and results in 41 minutes.

Rewatch our webinar with Uppsala University Hospital: how one lab unified short-read, long-read, and array workflows on a single platform, and how transparent AI ranks variants so the geneticist stays in control.